Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

755111

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Secure Psychiatric Units: Ethnic Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many patients from BME backgrounds spent a period of their care in locked wards in England during each of the last three years for which figures are available.
	tabling member printed	Lord Boateng
	uin	HL1119
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Data on the number of BME patients being treated in locked rehabilitation wards in England is not collected centrally, though we would expect trusts to pay close attention to such data.</p><p> </p><p>The Government welcomes the findings of the Care Quality Commission’s (CQC’s) report and shares its concerns about inappropriate use of locked rehabilitation wards. The department will consider the implications in discussion with NHS England, NHS Improvement and the CQC.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL1118 HL1120 question first answered 31/07/2017 13:25:20 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	147 label Biography information for Lord Boateng

755154

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Microplastics: Food
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government what assessment they have made of the risk to humans of microbeads and other plastics entering the human food chain.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL1162
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>On the basis of current information, the Food Standards Agency (FSA) considers it is unlikely that the presence of the low levels of microplastic particles that have been reported to occur in certain types of seafood would cause harm to consumers. The FSA will continue to monitor and assess emerging information concerning microplastics in seafood.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 14:27:14 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

755112

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Secure Psychiatric Units: Ethnic Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government what conclusions they have drawn from the Care Quality Commission review The state of care in mental health services 2014 to 2017, published on 20 July, as to the numbers and experience of BME patients in locked wards across England.
	tabling member printed	Lord Boateng
	uin	HL1120
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Data on the number of BME patients being treated in locked rehabilitation wards in England is not collected centrally, though we would expect trusts to pay close attention to such data.</p><p> </p><p>The Government welcomes the findings of the Care Quality Commission’s (CQC’s) report and shares its concerns about inappropriate use of locked rehabilitation wards. The department will consider the implications in discussion with NHS England, NHS Improvement and the CQC.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL1118 HL1119 question first answered 31/07/2017 13:25:20 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	147 label Biography information for Lord Boateng

755128

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Parkinson's Disease
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government what steps they are taking to improve access to timely and appropriate support for people with Parkinson's disease who are experiencing anxiety or depression.
	tabling member printed	Baroness Gale
	uin	HL1136
	answer	answer is ministerial correction date of answer 02/08/2017 answer text <p>As set out in <em>Implementing the Five Year Forward View for Mental Health</em> the expansion of Improving Access to Psychological Therapies services will focus on people with long term conditions, including neurological conditions such as Parkinson’s, and/or medically unexplained symptoms. New psychological therapy provision will see physical and mental health care provision co-located. Therapy will be integrated into existing medical pathways and services – either primary care, or secondary care services including neurology.</p><p>Although the majority of people with Parkinson’s can be cared for through routine access to primary and secondary care, NHS England commissions the specialised elements of Parkinson’s care that patients may receive from 24 specialised neurological treatment centres across England. Within these centres neurological multidisciplinary teams ensure patients can access a range of health professionals, including neurologists, neurosurgeons, clinical nurse specialists, psychologists, and that they can receive specialised treatment and support, according to their needs.</p><p>The Neurology Advisory Group will ensure that there is system alignment and a national approach when considering the recommendations, which will be of benefit to patients.</p><p>NHS England is also working with the Neurological Alliance, following the publication on 5 July 2017 of their report on mental health and neurological conditions, <em>Parity of esteem for people affected by neurological conditions: meeting the emotional, cognitive &amp; mental health needs of neurology patients</em>.</p><p>A copy of the report is attached.</p> answering member printed Lord O'Shaughnessy question first answered 02/08/2017 15:07:06 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name HL1136 Parity-of-esteem-for-people-affected-by-neuro-conditions-2017.pdf title Mental health and neurological conditions
	tabling member	2503 label Biography information for Baroness Gale

755177

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	HIV Infection: Foreign Nationals
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government whether the Department of Health has monitored risks associated with overseas visitors seeking or receiving HIV treatment, as set out in that Department's guidance on HIV treatment for overseas visitors in England from 1 October 2012; if so, how many such visitors have been identified; and whether any of those visitors were refused treatment.
	tabling member printed	Lord Ryder of Wensum
	uin	HL1185
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>From 1 October 2012, an amendment to the NHS (Charges to Overseas Visitors) Regulations meant that HIV treatment was no longer chargeable to any overseas visitors. This means that no-one should be charged for or refused HIV treatment based on residency.</p><p> </p><p>Public Health England monitors the country of birth of persons reported in England who are living with HIV infection and whether or not they are receiving HIV treatment according to their level of HIV-related immunosuppression. Information on their residency or visitor status is not recorded routinely by treating clinicians and therefore is not available.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 14:27:56 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1250 label Biography information for Lord Ryder of Wensum

755129

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Blood: Contamination
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government whether the findings of the 2009 independent report by Lord Archer of Sandwell on NHS supplied contaminated blood and blood products will be taken into account by the contaminated blood inquiry announced on 11 July.
	tabling member printed	Baroness Gould of Potternewton
	uin	HL1137
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>The focus of the inquiry will be on establishing the truth of what happened.</p><p> </p><p>Over the summer, the Government is consulting with those affected and key stakeholder groups to discuss the scope of the inquiry.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 13:25:47 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3573 label Biography information for Baroness Gould of Potternewton

755184

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government whether they plan to extend the HPV vaccination programme to boys in the UK; and if so, when.
	tabling member printed	Baroness Tonge
	uin	HL1192
	answer	answer is ministerial correction date of answer 02/08/2017 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) has recently reviewed whether or not the HPV vaccination programme for girls should be extended to adolescent boys.</p><p>In an interim statement on the 19 July, the JCVI stated that:</p><p>“Taking the evidence as a whole the Committee therefore is unable to recommend extension of the national HPV programme to adolescent boys according to the most robust cost-effectiveness analyses undertaken.”</p><p>It also recognised arguments made by stakeholders on the issue of equality of access and noted that these require consideration.</p><p>A copy of the statement from 19 July is attached.</p><p>The JCVI is consulting on these interim findings. Subject to the results of the consultation, the JCVI’s final advice is expected in November. The Department will consider and respond to this final advice in due course.</p> answering member printed Lord O'Shaughnessy question first answered 02/08/2017 14:59:10 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name Extending_HPV_Vaccination.pdf title JCVI statement on HPV vaccination
	tabling member	200 label Biography information for Baroness Tonge

755158

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: Prices
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government which public body is responsible for enforcing regulations concerning the retail prices of medicines; and what enforcement mechanisms are in place to sanction non-compliant retailers.
	tabling member printed	Baroness Mobarik
	uin	HL1167
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>The price of over-the-counter medicines charged by retailers is not subject to regulatory control. Competition between retailers acts to prevent excessive prices.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 14:29:38 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4335 label Biography information for Baroness Mobarik

755157

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 19 July (HL914), what plans they have to reduce the costs to the NHS of the supply of drugs such as Apomorphine that are long out of patent and simple and cheap to manufacture; and what consideration they have given to increasing supplies of such drugs by seeking suppliers who will invest in regulatory approvals in exchange for a fixed-price, fixed-term contract.
	tabling member printed	Lord Lucas
	uin	HL1165
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>The cost of branded medicines to the National Health Service is controlled by the voluntary pharmaceutical price regulation scheme or the statutory medicines price regulation scheme. Often when patents expire, generic versions enter the market and, as a result of competition, prices often go down.</p><p> </p><p>In primary care, the community pharmacy contractual framework provides an incentive for pharmacies to get the best medicines prices; in secondary care, a system of central tenders delivers similar levels of savings. In general, the system works well – the United Kingdom has the lowest generic prices across the Organisation for Economic Co-operation and Development.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 14:28:31 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1879 label Biography information for Lord Lucas

755110

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Secure Psychiatric Units: Ethnic Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government, what data are collected regarding the number of BME patients in locked wards in England; and what plans they have to impose new requirements for the collection of such data.
	tabling member printed	Lord Boateng
	uin	HL1118
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Data on the number of BME patients being treated in locked rehabilitation wards in England is not collected centrally, though we would expect trusts to pay close attention to such data.</p><p> </p><p>The Government welcomes the findings of the Care Quality Commission’s (CQC’s) report and shares its concerns about inappropriate use of locked rehabilitation wards. The department will consider the implications in discussion with NHS England, NHS Improvement and the CQC.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL1119 HL1120 question first answered 31/07/2017 13:25:20 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	147 label Biography information for Lord Boateng